New Biomarkers for Alzheimer's Disease, Depression, and Beyond
17 November 2026
2:00 PM - 3:00 PM EST
Session Speakers
Carol Taylor-Burds, National Institute of Neurological Disorders and Stroke (NINDS)
Meaghan Morris, Johns Hopkins University
Karlon H. Johnson, University of Miami Miller School of Medicine
Maura B. Dupont, Columbia University
Nisarg Desai, Emory University
Session Description
Physiological indicators of disease — known as biomarkers — can show up before symptoms do, opening the door for proactive treatment and precision therapies. Researchers will discuss the emergence of blood-based tests for both Alzheimer’s disease and depression as well as their limitations. Experts will also share unexpected indicators of Alzheimer’s disease from brain scans and the emerging uses of artificial intelligence for detecting and characterizing a range of diseases.